New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents

被引:38
作者
Chauhan, Kuldeep [1 ]
Sharma, Moni [1 ]
Trivedi, Priyanka [2 ]
Chaturvedi, Vinita [2 ]
Chauhan, Prem M. S. [1 ]
机构
[1] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226031, Uttar Pradesh, India
[2] CSIR, Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow 226031, Uttar Pradesh, India
关键词
Rhodanine; Tetrazole; Mycobacterium tuberculosis; Cytotoxicity; MYCOBACTERIUM-TUBERCULOSIS; RHODANINE; DERIVATIVES; DISCOVERY; INHIBITORS; SCAFFOLDS; TARGET;
D O I
10.1016/j.bmcl.2014.07.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In search of potential therapeutics for tuberculosis, we describe here the synthesis and in vitro antitubercular activity of a novel series of thiazolone piperazine tetrazole derivatives. Among all the synthesized derivatives, four compounds (10, 14,20 and 33) exhibited more potent activity (MIC = 3.08, 3.01, 2.62 and 2.51 mu M) than ethambutol (MIC = 9.78 mu M) and pyrazinamide (MIC = 101.53 mu M) against Mycobacterium tuberculosis. Furthermore, they displayed no toxicity against Vero cells (C1008) and mouse bone marrow derived macrophages (MBMDM phi)). These investigated analogues have emerged as possible lead molecule to enlarge the scope of the study. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4166 / 4170
页数:5
相关论文
共 34 条
[1]   Three-component one-pot synthetic route to 2-amino-5-alkylidene-thiazol-4-ones [J].
Anderluh, Marko ;
Jukic, Marko ;
Petric, Rok .
TETRAHEDRON, 2009, 65 (01) :344-350
[2]  
[Anonymous], 2007, CURR BIOACT COMPD
[3]  
[Anonymous], 2009, TREATM TUB GUID NAT, V4th edn
[4]   Novel inhibitors of an emerging target in Mycobacterium tuberculosis;: Substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis [J].
Babaoglu, K ;
Page, MA ;
Jones, VC ;
McNeil, MR ;
Dong, CJ ;
Naismith, JH ;
Lee, RE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3227-3230
[5]   Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis [J].
Bogatcheva, Elena ;
Hanrahan, Colleen ;
Nikonenko, Boris ;
Samala, Rowena ;
Chen, Ping ;
Gearhart, Jacqueline ;
Barbosa, Francis ;
Einck, Leo ;
Nacy, Carol A. ;
Protopopova, Marina .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) :3045-3048
[6]   Discovery of Triazine Mimetics As Potent Antileishmanial Agents [J].
Chauhan, Kuldeep ;
Sharma, Moni ;
Shivahare, Rahul ;
Debnath, Utsab ;
Gupta, Suman ;
Prabhakar, Yenamandra S. ;
Chauhan, Prem M. S. .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (11) :1108-1113
[7]   Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents [J].
Chauhan, Kuldeep ;
Sharma, Moni ;
Saxena, Juhi ;
Singh, Shiv Vardan ;
Trivedi, Priyanka ;
Srivastava, Kumkum ;
Puri, Sunil K. ;
Saxena, J. K. ;
Chaturvedi, Vinita ;
Chauhan, Prem. M. S. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :693-704
[8]   Discovery of a new class of dithiocarbamates and rhodanine scaffolds as potent antifungal agents: synthesis, biology and molecular docking [J].
Chauhan, Kuldeep ;
Sharma, Moni ;
Singh, Pratiksha ;
Kumar, Vikash ;
Shukla, Praveen K. ;
Siddiqi, Mohammad Imran ;
Chauhan, Prem. M. S. .
MEDCHEMCOMM, 2012, 3 (09) :1104-1110
[9]   1-isocyanomethylbenzotriazole and 2,2,4,4-tetramethylbutylisocyanide -: cleavable isocyanides useful-for the preparation of α-aminomethyl tetrazoles [J].
Dömling, Alexander ;
Beck, Barbara ;
Magnin-Lachaux, Marina .
TETRAHEDRON LETTERS, 2006, 47 (25) :4289-4291
[10]   Current Status and Research Strategies in Tuberculosis Drug Development [J].
Dover, Lynn G. ;
Coxon, Geoffrey D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (18) :6157-6165